Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist.

Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. Abstract Text:

    a e proudfootA E Proudfoot,c a powerC A Power,a j hoogewerfA J Hoogewerf,m o montjoventM O Montjovent,f borlatF Borlat,r e offordR E Offord,t n wellsT N Wells,

    Extension of recombinant human RANTES by a single residue at the amino terminus is sufficient to produce a potent and selective antagonist. RANTES is a proinflammatory cytokine that promotes cell accumulation and activation in chronic inflammatory diseases. When mature RANTES was expressed heterologously in Escherichia coli, the amino-terminal initiating methionine was not removed by the endogenous amino peptidases. This methionylated protein was fully folded but completely inactive in RANTES bioassays of calcium mobilization and chemotaxis of the promonocytic cell line THP-1. However, when assayed as an antagonist of both RANTES and macrophage inflammatory polypeptide-1 alpha (MIP-1 alpha) in these assays, the methionylated RANTES (Met-RANTES) inhibited the actions of both chemokines. T cell chemotaxis was similarly inhibited. The antagonistic effect was selective since Met-RANTES had no effect on interleukin-8- or monocyte chemotractant protein-1-induced responses in these cells. Met-RANTES can compete with both [125I]RANTES and [125I]IMP-1 alpha binding to THP-1 cells or to stably transfected HEK cells recombinantly expressing their common receptor, CC-CKR-1. These data show that the integrity of the amino terminus of RANTES is crucial to receptor binding and cellular activation.

    Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. Publishing Authors By Initials

    ae proudfootAE Proudfoot,ca powerCA Power,aj hoogewerfAJ Hoogewerf,mo montjoventMO Montjovent,f borlatF Borlat,re offordRE Offord,tn wellsTN Wells,

    For similar proteins: recombinant proteins research abstracts see: proteins: recombinant proteins research

    PUBMED ID PMID:

    MEDLINE DATE:

    Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Journal of biological chemistry

    VOLUME: 271

    Page Numbers: 2599-603

    Journal Abbreviation: J. Biol. Chem.

    ISSN: 0021-9258

    DAY: 2

    MONTH: Feb

    YEAR: 1996

    Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2985121

    Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. Keywords Mesh Terms:

    KEYWORDS: Recombinant Proteins

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. Information

    Substance Name: Methionine

    Registry Number: 63-68-3

    Grant and Affiliation Information for Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist.

    AFFILIATION: Glaxo Institute for Molecular Biology, Geneva, Switzerland. AEP6830@ggh.uk.co

    Country: UNITED STATES

    UNITED STATES Research PublicationUNITED STATES Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Biol Chem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News